Since SphK2 is the predominant isoform of the two S1P synthesizing enzymes in the brain (Blondeau et al., 2007) they analyzed SphK2 expression levels and activity in brain specimens from AD patients in comparison to non-demented individuals. Here, SPHK2 is linked to Alzheimer disease.